兰太药业隶属于上市公司--内蒙古兰太实业股份有限公司（股票代码600328）。旗下拥有内蒙古兰太药业有限责任公司、中国海洋大学兰太药业有限公司、内蒙古兰太药业营销有限公司、兰太实业生物工程公司、广东兰太康虹医药有限公司五家成员企业。
兰太药业总部位于呼和浩特市金川经济技术开发区，占地面积383亩，拥有符合国家GMP标准要求的全新制剂车间和一流的质检中心，多条生产线可同时规模生产片剂、胶囊剂、软胶囊剂、颗粒剂、针剂等多个剂型的产品。
作为国内第一家规模化生产天然胡萝卜素药品及藻类产品的高新技术企业，兰太药业本着 “ 科技先导、求实创新 ” 的经营理念，不断研制精品国药，并愿与各界同仁积极拓展合作空间，共同致力于人类健康事业。
Lantai Pharmaceutical is subordinate to the company on the stock market-Inner Mongolia Lantai industrial Share Co.,Ltd.(share code 600328) that possesses five members such as Inner Mongolia Lantai Pharmaceutical Co.,Ltd. , China Ocean University Lantai Pharmaceutical Marketing Co.,Ltd.,Lantai Industrial Bio-engineering Co.,Ltd.and Guangdong Lantai Kanghong Medical Co.,Ltd.
The company's headquarter is located at Jinchuan Economic & Technological Developing Zone in Huhhot,covering an area of 383 mu with a brand-new preparation workshop answering for the national GMP criterion and a top quality-testing center.With many production lines, simultaneously it can produce such products on large-scale as tablet, capsule, soft capsule,granule and injection.
Lantai Pharmaceutical, as being the first high-tech enterprise at home which can produce medicines of natural carotene and algae products on large-scale, with its management notion of "Science and technology is the precursor, being practical and innovating”, is trying to develop fine traditional  Chinese medicines and willing to actively expand the cooperative space with friends form all walks of life and jointly be devoted to struggling for the cause op people's health. |
